Abstract:The field of human genomics has progressed extensively since the publication of the first draft of the human genome in 2001. A simple search in PubMed using the keywords 'Human Genomics' produced a list of 5 521 articles published between the years 1990-2000, 15 740 in the first decade of the 21 st century (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010), 57 346 in the years 2011-2020, and from 2021 until 24 th August 2024, 32 856 articles have been published. Genomics has evidently found its application in a variety of research areas, diversifying our knowledge and understanding of the biological mechanisms of health and disease. This broad topic provided a platform specifically to earlycareer researchers (the first or co-first authors were all either enrolled on under-or postgraduate programmes) to publish their work in the fields of human and medical genomics and enable them to experience the collaborative aspects of the publishing process and workflows. The topic highlights studies that have made innovative use of genomics technologies to address issues related to maternal health, surgical treatment, and hearing loss.Lin et al. characterized the extrachromosomal circular DNA (eccDNA) from placental trophoblasts in placental and maternal plasma in a small number of samples to provide a proof-of-concept to use eccDNA as a biomarker for foetal growth restriction (FGR), a perinatal complication in foetuses. The authors performed eccDNA sequencing on a small number of samples and the analysis revealed the enrichment of both multi-chromosomal-fragment and single-fragment eccDNA in placenta, while only single-fragment eccDNA was identified in maternal plasma. The comparison of data from plasma between FGR and control groups led to the identification of abundant genes such as IGF2 and ZNF445 in the FGR group (linked to epigenetic regulation of gene expression and genomic imprinting), whereas ARG1, CCND1, CYP1A1, EZR, GPR68, MYO1C, and XPO4 (linked to response to vitamins, response to nutrient levels, and positive regulation of protein transport) were found to be abundant genes in the control group. Additionally, placental eccDNA-associated genes, those which were associated with immunity-related gene ontology terms, showed differential abundance between the FGR and control groups. This integrated data analysis from both placental and maternal plasma, combined with genomic annotation, offered insights into the potential of using eccDNA as biomarker of FGR and opens doors for using maternal plasma eccDNA signatures for future investigations into pregnancy-related diseases and complications.Qi et al. sheds light on a critical intersection of virology and reproductive health. This research is particularly timely given the ongoing global impact of COVID-19 and its far-reaching implications. The study examines the expression of SARS-CoV-2associated molecules in the endometrium, revealing significant insights into how these factors vary throughout the menstrual cycle. One of the most compelling aspects of this study is its focus on women with recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF). The significant reduction in TMPRSS2 (transmembrane protease serine 2) expression in the RIF group compared to the controls underscores the need for further investigation into how SARS-CoV-2 might exacerbate reproductive challenges. Similarly, in women with RPL, the peak expression of the host cell receptor basigin (BSG) during the window of implantation suggests a potential period of heightened vulnerability to SARS-CoV-2. Despite the limited sample numbers, this study is a crucial step toward understanding the interplay between viral infections and reproductive health and helps address the unique challenges faced by women with reproductive health issues.Fernández-Boyano et al. innovatively applied bioinformatics and artificial intelligence to design a model (eoPred) that can be used to identify early-onset preeclampsia from DNA methylation data and predict placental phenotype regardless of cell composition. Preeclampsia is a life-threatening condition and the leading cause of maternal and infant illness and death in the US. The package, which is available at https://www.bioconductor.org/packages/release/bioc/html/planet.html, is expected to significantly enhance current approaches at identifying placental insufficiency and be useful in larger, more complex EWAS studies as well.Turning from its use in maternal health, Kueng et al. shifts our focus to the practical use of genomics as a non-invasive tool to monitor allograft injury after solid organ transplants. The authors compared three methods currently used to quantify donor derived cell-free DNA (dd-cfDNA) and assessed the strengths and limitations of each. While the relative quantification of dd-cfDNA yielded comparable results between techniques, the absolute quantification methods showed mo -Abstract Truncated-

Perinatal genomics: Current research on genetic contributions to preterm birth and placental phenotype

Non-invasive Prenatal Testing Reveals Copy Number Variations Related to Pregnancy Complications

Insights from Multi-Omic Studies

Revisiting preeclampsia: a metabolic disorder of the placenta

Placental Pathology and the Developing Brain

Deciphering the Epigenetic Landscape: Placental Development and Its Role in Pregnancy Outcomes

The impact of periconceptional maternal lifestyle on clinical features and biomarkers of placental development and function: a systematic review

Placental Epigenome Impacts Fetal Development: Effects of Maternal Nutrients and Gut Microbiota

Transcriptomic analysis of the human placenta reveals trophoblast dysfunction and augmented Wnt signalling associated with spontaneous preterm birth

Maternal factors during pregnancy influencing maternal, fetal, and childhood outcomes

Pathway analysis of genetic factors associated with spontaneous preterm birth and pre-labor preterm rupture of membranes

Placental Microbiome and Its Role in Preterm

Editorial: Emerging talents in human and medical genomics

Advancing our knowledge of placental function and how it relates to the developing fetal brain

Gestational Age, Infection, and Suboptimal Maternal Prepregnancy BMI Independently Associate with Placental Histopathology in a Cohort of Pregnancies without Major Maternal Comorbidities

Placental Syndromes-A New Paradigm in Perinatology

Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension

Placental dysfunction: The core mechanism for poor neurodevelopmental outcomes in the offspring of preeclampsia pregnancies

Maternal–fetal and neonatal pharmacogenomics: a review of current literature

A comprehensive analysis of the association between placental pathology and recurrent preterm birth

Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia